Chondrosarcoma: A Diagnostic Imager's Guide to Decision Making and Patient Management

Chika I. Logie; Eric A. Walker; Jonathan A. Forsberg; Benjamin K. Potter; Mark D. Murphey

doi:10.1055/s-0033-1342967

Seminars in Musculoskeletal Radiology, Inhaltsverzeichnis

Semin Musculoskelet Radiol 2013; 17(02): 101-115
DOI: 10.1055/s-0033-1342967

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Chondrosarcoma: A Diagnostic Imager's Guide to Decision Making and Patient Management

Autor*innen

Chika I. Logie

¹Musculoskeletal Section, American Institute for Radiologic Pathology (AIRP), Silver Spring, Maryland

³Department of Radiology and Nuclear Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland
Eric A. Walker

²Department of Radiology, Milton S. Hershey Medical Center, Pennsylvania State, Hershey, Pennsylvania

³Department of Radiology and Nuclear Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland
Jonathan A. Forsberg

⁴Division of Orthopaedic Oncology and Orthopaedic Research, Department of Orthopaedic Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland
Benjamin K. Potter

⁴Division of Orthopaedic Oncology and Orthopaedic Research, Department of Orthopaedic Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland
Mark D. Murphey

¹Musculoskeletal Section, American Institute for Radiologic Pathology (AIRP), Silver Spring, Maryland

³Department of Radiology and Nuclear Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland

Abstract

Chondrosarcoma is the third most common primary malignant bone tumor. Currently, outcomes are based largely on a histologic grading scale described by the World Health Organization (WHO) Classification of Bone Tumors (2002). This classification scheme possesses evident utility in the evaluation and management of higher grade tumors, but it is often unable to distinguish enchondromas from low-grade chondrosarcomas. This is problematic when low-grade lesions that are histologically similar to enchondromas demonstrate aggressive imaging features. Because histologic classification alone often belies the clinical significance of chondroid lesions, it is also important to consider radiologic staging as part of the clinical decision making process. This article focuses on medical decision support considerations relevant when confronted with this challenging subset of chondroid tumors, particularly differentiating the benign enchondroma from its notorious relative, the low-grade chondrosarcoma. In doing so, we present a review of the salient imaging features and discuss key differentiating characteristics.

Keywords

enchondroma - chondrosarcoma - chondroid tumors - cartilage tumors - histologic grading - radiologic staging

Volltext

Referenzen

References
1 Khurana JS, McCarthy EF, Zhang PJ. Tumors and Tumor-Like Lesions of Bone. In: Essentials in Bone and Soft-Tissue Pathology. Boston, MA: Springer; 2010: 78-99
2 Wu LC, Kleinerman RA, Curtis RE, Savage SA, de González AB. Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type. Cancer Epidemiol Biomarkers Prev 2012; 21 (11) 1993-1999
3 Wu JS, Hochman MG. Bone Tumors. A Practical Guide to Imaging. New York, NY: Springer Science + Business Media; 2012
4 Brien EW, Mirra JM, Kerr R. Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. I. The intramedullary cartilage tumors. Skeletal Radiol 1997; 26 (6) 325-353
5 Szendröi M, Sim F. Color atlas of clinical orthopedics. J R Soc Med 2009; 73 (12) 901
6 Rizzo M, Ghert MA, Harrelson JM, Scully SP. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. Clin Orthop Relat Res 2001; 391 (391) 224-233
7 Khurana JS. Bone Pathology. 2009 . Available at: www.springer.com/?SGWID=0-102-1297-173729593-0
8 Söderström M, Ekfors TO, Böhling TO, Teppo LHI, Vuorio EI, Aro HT. No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990. Acta Orthop Scand 2003; 74 (3) 344-350
9 Huvos AG. Bone Tumors: Diagnosis, Treatment, and Prognosis. 2nd ed. Philadelphia, PA: Saunders; 1990
10 Choi B-B, Jee W-H, Sunwoo H-J , et al. MR differentiation of low-grade chondrosarcoma from enchondroma. Clin Imaging 2012; ; October 3 (Epub ahead of print)
11 Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer 1977; 40 (2) 818-831
12 Ferrer-Santacreu EM, Ortiz-Cruz EJ, González-López JM, Pérez Fernández E. Enchondroma versus low-grade chondrosarcoma in appendicular skeleton: clinical and radiological criteria. J Oncol 2012; 2012: 1-6
13 Verdegaal SH, Brouwers HF, van Zwet EW, Hogendoorn PC, Taminiau AH. Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting. J Bone Joint Surg Am 2012; 94 (13) 1201-1207
14 Donati D, Colangeli S, Colangeli M, Di Bella C, Bertoni F. Surgical treatment of grade I central chondrosarcoma. Clin Orthop Relat Res 2010; 468 (2) 581-589
15 Bauer HCF, Brosjö O, Kreicbergs A, Lindholm J. Low risk of recurrence of enchondroma and low-grade chondrosarcoma in extremities. 80 patients followed for 2-25 years. Acta Orthop Scand 1995; 66 (3) 283-288
16 Widhe B, Bauer HCF. Scandinavian Sarcoma Group. Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: a population-based Scandinavian Sarcoma Group study of 106 patients. J Thorac Cardiovasc Surg 2009; 137 (3) 610-614
17 Janzen L, Logan PM, O'Connell JX, Connell DG, Munk PL. Intramedullary chondroid tumors of bone: correlation of abnormal peritumoral marrow and soft-tissue MRI signal with tumor type. Skeletal Radiol 1997; 26 (2) 100-106
18 Jelinek JS, Murphey MD, Welker JA , et al. Diagnosis of primary bone tumors with image-guided percutaneous biopsy: experience with 110 tumors. Radiology 2002; 223 (3) 731-737
19 Ragsdale BD, Sweet DE, Vinh TN. Radiology as gross pathology in evaluating chondroid lesions. Hum Pathol 1989; 20 (10) 930-951
20 Steiner GC, Scweitzer ME, Samuel K, Abdelwahab IF. Chondrosarcoma of the femur with histology-imaging correlation of tumor growth–preliminary observations concerning periosteal new bone formation and soft tissue extension. Bull NYU Hosp Jt Dis 2011; 69 (2) 158-167
21 Logie CI, Smith SE, Nagy P. Evaluation of resident familiarity and utilization of the ACR musculoskeletal study appropriateness criteria in the context of medical decision support. Acad Radiol 2010; 17 (2) 251-254
22 Unni KK, Dahlin DC. Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases. 5th ed. Philadelphia, PA: Lippincott-Raven; 1996
23 Murphey MD, Walker EA, Wilson AJ, Kransdorf MJ, Temple HT, Gannon FH. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. Radiographics 2003; 23 (5) 1245-1278
24 Mirra JM, Picci P, Gold RH. Bone Tumors: Clinical, Radiologic, and Pathologic Correlations. Philadelphia, PA: Lea & Febiger; 1989
25 Welkerling H, Kratz S, Ewerbeck V, Delling G. A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data. . Virchows Arch 2003; 443 (6) 725-733
26 Yoo HJ, Hong SH, Choi JY , et al. Differentiating high-grade from low-grade chondrosarcoma with MR imaging. Eur Radiol 2009; 19 (12) 3008-3014
27 Crim JR, Mirra JM. Enchondroma protuberans. Report of a case and its distinction from chondrosarcoma and osteochondroma adjacent to an enchondroma. Skeletal Radiol 1990; 19 (6) 431-434
28 Murphey MD, Flemming DJ, Boyea SR, Bojescul JA, Sweet DE, Temple HT. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics 1998; 18 (5) 1213-1237 ; quiz 1244–1245
29 Pritchard DJ, Lunke RJ, Taylor WF, Dahlin DC, Medley BE. Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer 1980; 45 (1) 149-157
30 Soldatos T, McCarthy EF, Attar S, Carrino JA, Fayad LM. Imaging features of chondrosarcoma. J Comput Assist Tomogr 2011; 35 (4) 504-511
31 Strike SA, McCarthy EF. Chondrosarcoma of the spine: a series of 16 cases and a review of the literature. Iowa Orthop J 2011; 31: 154-159
32 Bjornsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ. Primary chondrosarcoma of long bones and limb girdles. Cancer 1998; 83 (10) 2105-2119
33 Kocher MS, Jupiter JB. Enchondroma versus chondrosarcoma of the phalanx. . Orthopedics 2000; 23 (5) 493-494
34 Kendell S, Collins M, Adkins M, Sundaram M, Unni K. Radiographic differentiation of enchondroma from low-grade chondrosarcoma in the fibula. Skeletal Radiol 2004; 33 (8) 458-466
35 Preidler KW, Brossmann J, Daenen B , et al. Measurements of cortical thickness in experimentally created endosteal bone lesions: a comparison of radiography, CT, MR imaging, and anatomic sections. AJR Am J Roentgenol 1997; 168 (6) 1501-1505
36 De Beuckeleer LH, De Schepper AM, Ramon F. Magnetic resonance imaging of cartilaginous tumors: is it useful or necessary?. Skeletal Radiol 1996; 25 (2) 137-141
37 De Beuckeleer LH, De Schepper AM, Ramon F, Somville J. Magnetic resonance imaging of cartilaginous tumors: a retrospective study of 79 patients. Eur J Radiol 1995; 21 (1) 34-40
38 De Beuckeleer LH, De Schepper AM, Ramon F. Magnetic resonance imaging of cartilaginous tumors: is it useful or necessary?. Skeletal Radiol 1996; 25 (2) 137-141
39 Flemming DJ, Murphey MD. Enchondroma and chondrosarcoma. Semin Musculoskelet Radiol 2000; 4 (1) 59-71
40 Geirnaerdt MJ, Hogendoorn PC, Bloem JL, Taminiau AH, van der Woude HJ. Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology 2000; 214 (2) 539-546
41 Kobayashi H, Kotoura Y, Hosono M , et al. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy. Clin Nucl Med 1995; 20 (4) 361-364
42 Feldman F, Heertum RV, Saxena C, Parisien M. 18FDG-PET applications for cartilage neoplasms. Skeletal Radiol 2005; 34 (7) 367-374
43 Brenner W, Conrad EU, Eary JF. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur J Nucl Med Mol Imaging 2004; 31 (2) 189-195
44 Purandare NC, Rangarajan V, Agarwal M , et al. Integrated PET/CT in evaluating sarcomatous transformation in osteochondromas. Clin Nucl Med 2009; 34 (6) 350-354
45 Aoki J, Watanabe H, Shinozaki T, Tokunaga M, Inoue T, Endo K. FDG-PET in differential diagnosis and grading of chondrosarcomas. J Comput Assist Tomogr 1999; 23 (4) 603-608
46 Mirra JM, Gold R, Downs J, Eckardt JJ. A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. Clin Orthopaedics Related Res 1985; (201) 214-237
47 Hudson TM, Chew FS, Manaster BJ. Radionuclide bone scanning of medullary chondrosarcoma. AJR Am J Roentgenol 1982; 139 (6) 1071-1076
48 Hickey M, Farrokhyar F, Deheshi B, Turcotte R, Ghert M. A systematic review and meta-analysis of intralesional versus wide resection for intramedullary grade I chondrosarcoma of the extremities. Ann Surg Oncol 2011; 18 (6) 1705-1709